Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
07/23/1997 | EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus |
07/23/1997 | EP0785262A1 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
07/23/1997 | EP0785261A1 Glutamyl-tRNA synthetase from Staphylococcus aureus |
07/23/1997 | EP0785260A1 Alanyl-tRNA synthetase of Staphylococcus aureus |
07/23/1997 | EP0785258A1 Staphylococcus aureus tyrosyl-tRNA synthetase |
07/23/1997 | EP0785257A1 Cysteinyl-tRNA synthetase from Staphylococcus aureus |
07/23/1997 | EP0785214A2 Amylase inhibitors |
07/23/1997 | EP0785195A1 Piperidine or tetrahydropyridine derivatives having affinity for the serotonin 5-HTIA receptor |
07/23/1997 | EP0784983A2 Use of extracellular hemoglobin |
07/23/1997 | EP0784980A1 Collagen hydrolysis accelerator |
07/23/1997 | EP0784978A2 Agents for inhibiting accumulation of visceral fat |
07/23/1997 | EP0784976A1 Immunosuppressive-activity potentiating compositions containing ascorbyl tocopheryl phosphoric acid diesters |
07/23/1997 | EP0784753A1 Axial flow valve system for linear compressor |
07/23/1997 | EP0784690A1 Complementary adenoviral vector systems and cell lines |
07/23/1997 | EP0784677A1 Inhibitor of stem cell proliferation and uses thereof |
07/23/1997 | EP0784672A1 Human inositol monophosphatase h1 |
07/23/1997 | EP0784629A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
07/23/1997 | EP0784628A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
07/23/1997 | EP0784627A1 Process for preparing 17-beta-substituted-androsta-3,5-dien-3-carboxylic acids |
07/23/1997 | EP0784604A1 Processes for the preparation of (e)-2-fluoromethylene-4-(4-fluorophenyl) butylamine and alkali metal salts of diformylamide |
07/23/1997 | EP0784478A1 Inhibition of endothelin-1 to reduce inflammatory processes |
07/23/1997 | EP0784473A1 Inhibitors of farnesyl-protein transferase |
07/23/1997 | EP0784430A1 Method for reducing unwanted cellular adhesions |
07/23/1997 | EP0784429A1 Method and formulation of stimulating nitric oxide synthesis |
07/23/1997 | EP0649464B1 Transfection of vertebrate cells e.g. by homologous recombination |
07/23/1997 | EP0554400B1 Retroviral protease inhibitors |
07/23/1997 | EP0540717B1 UNSATURATED 17$g(b)-SUBSTITUTED 3-CARBOXY STEROIDS |
07/23/1997 | EP0538332B1 Polycyclic guanine derivatives |
07/23/1997 | EP0474846B1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides |
07/23/1997 | EP0451194B1 Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
07/23/1997 | CN1155281A Noval pyrimidine derivatives and prepn. processes thereof |
07/23/1997 | CN1155276A Enzyme inhibitors |
07/23/1997 | CN1154863A Technology for making medicated core of treatment and health-care whip and using method thereof |
07/23/1997 | CN1154855A Tonic medicine-essence of pearl and long-noded pit viper |
07/23/1997 | CN1154846A Method for production of solid tea fungus active medicinal preparation |
07/22/1997 | US5650504 Nucleic acids encoding eck receptor ligands |
07/22/1997 | US5650495 Protein having an affinity for a heparin-binding growth factor |
07/22/1997 | US5650494 Process for refolding recombinantly produced TGF-β-like proteins |
07/22/1997 | US5650492 P-40 homodimer of interleukin-12 |
07/22/1997 | US5650445 3,4-diphenyl-3-hexene |
07/22/1997 | US5650439 Treatment of parkinson*s disease |
07/22/1997 | US5650433 Chondroprotective agents |
07/22/1997 | US5650429 Use of DL-(+/-)-α-lipoic acid, D-(+)-α-lipoic acid, α-lipoic acid in reduced or oxidized form or salts for treating circulatory disorders |
07/22/1997 | US5650427 Antidepressants |
07/22/1997 | US5650426 Enantiomers of carbazole derivatives as 5-HT.sub. 1-like agonists |
07/22/1997 | US5650422 Treatment of emphysema, arthritis or pancreatitis |
07/22/1997 | US5650414 Pyrazolopyridines or imidazolopyridines |
07/22/1997 | US5650409 Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
07/22/1997 | US5650408 Thiazolo benzazepine containing dual action inhibitors |
07/22/1997 | US5650292 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
07/22/1997 | US5650168 Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance |
07/22/1997 | US5650145 Dermatological/cosmetic compositions comprising antifungal and antibacterial compounds and reduction of hair loss therewith |
07/22/1997 | US5650137 Cosmetic composition containing a superoxide dismutase and a porphyrin |
07/20/1997 | CA2195291A1 Bioactive substance k93-0711 1-1 and 1-2, and process for production thereof |
07/19/1997 | CA2195051A1 Amylase inhibitors |
07/18/1997 | CA2195371A1 Immunosuppressive-activity potentiating compositions |
07/17/1997 | WO1997025428A1 Apo-2 ligand |
07/17/1997 | WO1997025425A1 Wsx receptor and ligands |
07/17/1997 | WO1997025421A2 PROTEIN INDUCED BY DEPRENYL$m(3) |
07/17/1997 | WO1997025418A1 Angiotensin converting enzyme inhibitors |
07/17/1997 | WO1997025351A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
07/17/1997 | WO1997025342A1 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione |
07/17/1997 | WO1997025331A1 Heterocycle-condensed morphinoid derivatives (ii) |
07/17/1997 | WO1997025328A1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF, INTERMEDIATES THEREOF AND DRUGS CONTAINING SAME |
07/17/1997 | WO1997025324A1 Substituted aza- and diazacycloheptane and cyclooctane compounds and their use |
07/17/1997 | WO1997025323A1 Fibrinogen receptor antagonists |
07/17/1997 | WO1997025322A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
07/17/1997 | WO1997025317A1 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity |
07/17/1997 | WO1997025315A1 Novel n-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity |
07/17/1997 | WO1997025311A1 Novel tricyclic compounds and drug compositions containing the same |
07/17/1997 | WO1997025059A1 Using serine-proteases for acne and inflamed comedones |
07/17/1997 | WO1997025057A1 Aqueous prolonged release formulation |
07/17/1997 | WO1997025048A1 Novel cycloalkyl substituted imidazoles |
07/17/1997 | WO1997025047A1 Novel cycloalkyl substituded imidazoles |
07/17/1997 | WO1997025046A1 Novel substituted imidazole compounds |
07/17/1997 | WO1997025045A1 Novel substituted imidazole compounds |
07/17/1997 | WO1997025042A1 Use of an agonist of ppar-alpha and ppar-gamma for the treatment of syndrom x |
07/17/1997 | WO1997017937A3 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders |
07/17/1997 | DE19600934A1 Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung Substituted aza and Diazacycloheptan- and Cyclooctanverbindungen and their use |
07/17/1997 | CA2666263A1 Apo-2 ligand |
07/17/1997 | CA2242632A1 Use of an antagonist of ppar-alpha and ppar-gamma for the treatment of syndrome x |
07/17/1997 | CA2242609A1 Heterocycle-condensed morphinoid derivatives (ii) |
07/17/1997 | CA2242327A1 Novel substituted imidazole compounds |
07/17/1997 | CA2241564A1 Wsx receptor and ligands |
07/17/1997 | CA2241169A1 Inhibitors of madcam-1-mediated interactions and methods of use therefor |
07/17/1997 | CA2240685A1 Aqueous prolonged release formulation |
07/17/1997 | CA2239254A1 5h,10h-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives, preparation thereof, intermediates thereof and drugs containing same |
07/17/1997 | CA2195157A1 (1h-indol-4-yl)-piperidine or tetrahydropyridine ethylamines and ethylcarboxamides |
07/16/1997 | EP0784093A1 Osteoprotegerin |
07/16/1997 | EP0784058A1 Derivatives of aspartic acid, preparation and use thereof |
07/16/1997 | EP0783893A1 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |
07/16/1997 | EP0783568A1 Fibroblasts for the treatment of muscular disorders |
07/16/1997 | EP0783567A1 Human galactokinase gene |
07/16/1997 | EP0783526A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
07/16/1997 | EP0783518A1 Inhibitors of farnesyl-protein transferase |
07/16/1997 | EP0783517A2 Thiol-free inhibitors of farnesyl-protein transferase |
07/16/1997 | EP0783510A1 Human potassium channel 1 and 2 proteins |
07/16/1997 | EP0783509A1 Human transcription factor iia |
07/16/1997 | EP0783508A1 The oligosaccharide structure of a ligand for e and p selectin |
07/16/1997 | EP0783507A1 Compounds useful as antiproliferative agents and garft inhibitors |